Back to Search
Start Over
Maternal dietary uridine causes, and deoxyuridine prevents, neural tube closure defects in a mouse model of folate-responsive neural tube defects.
- Source :
-
The American journal of clinical nutrition [Am J Clin Nutr] 2015 Apr; Vol. 101 (4), pp. 860-9. Date of Electronic Publication: 2015 Jan 28. - Publication Year :
- 2015
-
Abstract
- Background: Folic acid prevents neural tube closure defects (NTDs), but the causal metabolic pathways have not been established. Serine hydroxymethyltransferase 1 (SHMT1) is an essential scaffold protein in folate-dependent de novo thymidylate synthesis in the nucleus. SHMT1-deficient mice provide a model to investigate folic acid-responsive NTDs wherein disruption of de novo thymidylate synthesis impairs neural tube closure.<br />Objective: We examined the effects of maternal supplementation with the pyrimidine nucleosides uridine, thymidine, or deoxyuridine with and without folate deficiency on NTD incidence in the Shmt1 mouse model.<br />Design: Shmt1(+/+) and Shmt1(-/-) female mice fed folate-replete or folate-deficient diets and supplemented with uridine, thymidine, or deoxyuridine were bred, and litters (n = 10-23 per group) were examined for the presence of NTDs. Biomarkers of impaired folate status and metabolism were measured, including plasma nucleosides, hepatic uracil content, maternal plasma folate concentrations, and incorporation of nucleoside precursors into DNA.<br />Results: Shmt1(+/-) and Shmt1(-/-) embryos from dams fed the folate-deficient diet were susceptible to NTDs. No NTDs were observed in litters from dams fed the folate-deficient diet supplemented with deoxyuridine. Surprisingly, uridine supplementation increased NTD incidence, independent of embryo genotype and dietary folic acid. These dietary nucleosides did not affect maternal hepatic uracil accumulation in DNA but did affect plasma folate concentrations.<br />Conclusions: Maternal deoxyuridine supplementation prevented NTDs in dams fed the folate-deficient diet, whereas maternal uridine supplementation increased NTD incidence, independent of folate and embryo genotype. These findings provide new insights into the metabolic impairments and mechanisms of folate-responsive NTDs resulting from decreased Shmt1 expression.<br /> (© 2015 American Society for Nutrition.)
- Subjects :
- Animals
Deoxyuridine blood
Disease Models, Animal
Female
Folic Acid blood
Folic Acid Deficiency drug therapy
Glycine Hydroxymethyltransferase genetics
Glycine Hydroxymethyltransferase metabolism
HeLa Cells
Humans
Maternal Nutritional Physiological Phenomena
Mice
Neural Tube drug effects
Neural Tube Defects blood
Neural Tube Defects etiology
Pregnancy
Thymidine administration & dosage
Thymidine adverse effects
Thymidine blood
Uracil metabolism
Uridine blood
Deoxyuridine administration & dosage
Folic Acid administration & dosage
Neural Tube Defects drug therapy
Uridine administration & dosage
Uridine adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1938-3207
- Volume :
- 101
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- The American journal of clinical nutrition
- Publication Type :
- Academic Journal
- Accession number :
- 25833982
- Full Text :
- https://doi.org/10.3945/ajcn.114.097279